EXCLUSIVE: Months ago, scientists offered a plan to use coronavirus survivors’ blood to make an upper-arm shot that could inoculate people for months, until a vaccine exists. But HHS officials rejected the plan, and manufacturers declined to make them. 1/ https://www.latimes.com/science/story/2020-07-10/injection-prevent-coronavirus-feds-manufacturers-fail-to-act">https://www.latimes.com/science/s...

Short-term immunity shots work for other diseases; they could have been developed to protect health workers, nursing home residents, or even for use at public drive-through sites. Researchers implored the BARDA, the FDA and the Hill — still no progress. 2/ https://www.latimes.com/science/story/2020-07-10/injection-prevent-coronavirus-feds-manufacturers-fail-to-act">https://www.latimes.com/science/s...

There could be a financial dimension: Pharmaceutical companies knew better than to invest in a shot that might soon be replaced by a vaccine, critics say. They& #39;re pushing for gov. grants — saying the price tag is a tiny fraction of Op. Warp Speed. 3/ https://www.latimes.com/science/story/2020-07-10/injection-prevent-coronavirus-feds-manufacturers-fail-to-act">https://www.latimes.com/science/s...

Fauci told me short-term immunity shots were “very attractive,” but said hospital plasma treatments must prove efficacious first. Critics ask why the two can’t run in tandem trials, given the number of lives on the line. 4/4 https://www.latimes.com/science/story/2020-07-10/injection-prevent-coronavirus-feds-manufacturers-fail-to-act">https://www.latimes.com/science/s...